These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Blood levels of flupenthixol in patients with acute and chronic schizophrenia. Johnstone EC; Bourne RC; Cotes PM; Crow TJ; Ferrier IN; Owen F; Robinson JD Ciba Found Symp; 1979; (74):99-114. PubMed ID: 261691 [TBL] [Abstract][Full Text] [Related]
26. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine. Friedman J; Ault K; Powchik P Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089 [No Abstract] [Full Text] [Related]
27. Antiautistic effect of flupentixol. De Buck RP Acta Psychiatr Belg; 1974 Sep; 74(5):520-5. PubMed ID: 4471032 [No Abstract] [Full Text] [Related]
28. Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl. Abuzzahab FS; Zimmermann RL Adv Biochem Psychopharmacol; 1980; 24():547-50. PubMed ID: 7405675 [No Abstract] [Full Text] [Related]
29. [Quality of life and therapeutic result in outpatients with schizophrenia under flupenthixol treatment]. Kühn KU; Quednow BB; Landen H; Riedel M; Thiel M Fortschr Neurol Psychiatr; 2004 Jul; 72(7):397-403. PubMed ID: 15252753 [TBL] [Abstract][Full Text] [Related]
30. [Total illness costs of schizophrenia and monetary evaluation of prevention of recurrence exemplified by a standard depot neuroleptic (flupenthixol decanoate)]. Osterheider M; Franken-Hiep K; Horn R Psychiatr Prax; 1998 Jan; 25(1):38-43. PubMed ID: 9530768 [TBL] [Abstract][Full Text] [Related]
31. [Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia]. Philipp M; Lesch OM; Schmauss M; Dose M; Glaser T Psychiatr Prax; 2003 May; 30 Suppl 2():S94-6. PubMed ID: 14509050 [TBL] [Abstract][Full Text] [Related]
32. The use of flupenthixol ('Fluanxol') in the management of behavioural disorders in disturbed and psychotic children. de Coninck G; Denis A Pharmatherapeutica; 1982; 3(3):209-14. PubMed ID: 7134229 [TBL] [Abstract][Full Text] [Related]
33. Auto-amputation of the tongue associated with flupenthixol induced extrapyramidal symptoms. Pantanowitz L; Berk M Int Clin Psychopharmacol; 1999 Mar; 14(2):129-31. PubMed ID: 10220129 [TBL] [Abstract][Full Text] [Related]
35. A new dosage schedule for pimozide in the acute stabilisation and maintenance treatment of psychosis. Noordhuizen GJ Acta Psychiatr Belg; 1980; 80(3):329-40. PubMed ID: 7211424 [TBL] [Abstract][Full Text] [Related]
36. Biochemical and neuroendocrine approaches to a malignant syndrome of neuroleptics. Ansseau M; Diricq S; Grisar T; Collard J Acta Psychiatr Belg; 1980; 80(5):600-6. PubMed ID: 7234452 [TBL] [Abstract][Full Text] [Related]
37. [Flupenthixol versus haloperidol in acute psychotic episodes]. Parent M; Toussaint C Acta Psychiatr Belg; 1982; 82(6):617-31. PubMed ID: 7183131 [TBL] [Abstract][Full Text] [Related]
38. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy. Wilson LG; Roberts RW; Gerber CJ; Johnson MH J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441 [TBL] [Abstract][Full Text] [Related]
39. Plasma pimozide profiles in chronic schizophrenics. McCreadie RG; Heykants JJ; Chalmers A; Anderson AM Br J Clin Pharmacol; 1979 May; 7(5):533-4. PubMed ID: 475950 [No Abstract] [Full Text] [Related]
40. Long-term treatment with flupentixol results of a post-marketing surveillance study. Messer T; Glaser T; Landen H; Schmauss M J Psychopharmacol; 2009 Sep; 23(7):805-13. PubMed ID: 18562418 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]